Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experience

Bispecific antibodies (BsAbs) can cause profound hypogammaglobulinemia. Conventional infection prophylaxis has utilized weight-based IVIG dosing. However, the use of flat IVIG dosing can significantly reduce IVIG utilization. We evaluated hypogammaglobulinemia and infection risk in relapsed/refracto...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Naimisha Marneni, Spencer Lessans, Bhagirathbhai Dholaria, Salyka Sengsayadeth, Eden A. Biltibo, Vivek Patel, Shakthi Bhaskar, Reena Jayani, Sanjay Mohan, Ashwin Kishtagari, David Morgan, Olalekan O. Oluwole, Bipin N. Savani, Adetola A. Kassim, Muhamed Baljevic
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2026-02-01
Reeks:	Frontiers in Immunology
Onderwerpen:	bispecific antibodies (BsAbs) cellular therapies hypogammaglobinemia IVIG (intravenous immunoglobulin) administration multiple myeloma
Online toegang:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1721820/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!